Norman L. Halleen
Keine laufenden Positionen mehr
Profil
Norm Halleen was Interim Chief Financial Officer of Aradigm Corp.
He was Vice President of Finance and Chief Financial Officer for Aradigm from 1999 to 2001, Senior Vice President and Chief Financial Officer of InterMune, Inc. and Vice President and Chief Financial Officer of Syrrx, Inc. Mr. Halleen received a BA degree from Stanford University and an MBA from Harvard Graduate School of Business.
Ehemalige bekannte Positionen von Norman L. Halleen
| Unternehmen | Position | Ende |
|---|---|---|
| ARADIGM CORPORATION | Finanzdirektor/CFO | 22.09.2008 |
| INTERMUNE INC | Finanzdirektor/CFO | 28.07.2006 |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Finanzdirektor/CFO | 01.06.2003 |
| Collagen Corp. | Finanzdirektor/CFO | 01.10.1999 |
Ausbildung von Norman L. Halleen
| Stanford University | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Syrrx, Inc.
Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | Health Technology |
| Collagen Corp. | Health Technology |
